ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03303339
Brief Title: Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).

First Submitted : September 6, 2017
First Submitted that Met QC Criteria : October 2, 2017
First Posted : October 6, 2017

Last Update Submitted that Met QC Criteria : December 13, 2018
Last Update Posted : December 14, 2018